Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any primary ciliary dyskinesia in which the cause of the disease is a mutation in the CCDC39 gene.
Features include always present findings: Immotile sperm, Rhinorrhea, Cough, and Wheezing and others; and very common findings: Bronchiectasis and Neonatal respiratory distress. 20 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Lungs and breathing | 7 | Recurrent pneumonia, Bronchiectasis, Wheezing |
CCDC39 encodes coiled-coil domain 39 molecular ruler complex subunit (941 aa). Required for assembly of dynein regulatory complex (DRC) and inner dynein arm (IDA) complexes, which are responsible for ciliary beat regulation, thereby playing a central role in motility in cilia and flagella.
Primary ciliary dyskinesia 14 is caused by mutations in the CCDC39 gene on chromosome 3.
CCDC39 is classified as a druggable target with score 0.0.
Genetic testing for CCDC39 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for primary ciliary dyskinesia 14 has been reported in the published literature.
Phenotype severity distribution: 7 always present features, 2 very common features, 3 common features.
No clinical trials have been registered for primary ciliary dyskinesia 14.
156 publications have been identified in PubMed for primary ciliary dyskinesia 14. Kisho has analyzed 82 by research type. Research spans Epidemiology / Natural History (27%), Diagnostic / Biomarker (17%), and Case Report / Case Series (17%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 22 | 27% |
Data assembled from 6 of 12 sources · Last updated Sep 19, 2026, 2:35 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Hormones
1 |
Male infertility |
Brain and nerves | 1 | Ciliary dyskinesia |
Blood and immune system | 1 | Recurrent respiratory infections |
Ears | 1 | Otitis media |
Pregnancy and birth | 1 | Neonatal respiratory distress |
Testing and diagnosis research |
14 |
17% |
Patient case studies | 14 | 17% |
Laboratory research | 14 | 17% |
Research summaries | 11 | 13% |
Clinical study results | 4 | 5% |
New treatment approaches | 3 | 4% |
AbdulWahab A (2026). [PMID: 41267578](https://pubmed.ncbi.nlm.nih.gov/41267578/). *Clin Genet*. [Epidemiology / Natural History]
Levine H (2026). [PMID: 41022559](https://pubmed.ncbi.nlm.nih.gov/41022559/). *Respir Care*. [Diagnostic / Biomarker]
Wohlgemuth K (2026). [PMID: 42089334](https://pubmed.ncbi.nlm.nih.gov/42089334/). *Am J Respir Cell Mol Biol*. [Basic Science / Preclinical]
Khalil I (2026). [PMID: 41767071](https://pubmed.ncbi.nlm.nih.gov/41767071/). *Clin Case Rep*. [Case Report / Case Series]
Hu S (2026). [PMID: 42134984](https://pubmed.ncbi.nlm.nih.gov/42134984/). *Eur Respir J*. [Diagnostic / Biomarker]
Thawanaphong S (2026). [PMID: 42104487](https://pubmed.ncbi.nlm.nih.gov/42104487/). *Allergy Asthma Clin Immunol*. [Diagnostic / Biomarker]
Arias K (2026). [PMID: 41626619](https://pubmed.ncbi.nlm.nih.gov/41626619/). *Urol Case Rep*. [Case Report / Case Series]
Bertini V (2026). [PMID: 42061474](https://pubmed.ncbi.nlm.nih.gov/42061474/). *Respir Med*. [Gene Therapy / Novel Therapeutics]
Batu U (2026). [PMID: 41837195](https://pubmed.ncbi.nlm.nih.gov/41837195/). *Front Pediatr*. [Gene Therapy / Novel Therapeutics]
Ito M (2026). [PMID: 41062319](https://pubmed.ncbi.nlm.nih.gov/41062319/). *Intern Med*. [Case Report / Case Series]